Log In
Print this Print this

Autologous CD34+ cells

  Manage Alerts
Collapse Summary General Information
Company Fondazione Telethon
DescriptionAutologous CD34+ cells transfected with a lentiviral vector encoding functional Wiskott-Aldrich syndrome protein
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus
Latest Stage of DevelopmentPhase I/II
Standard Indication Hematology (unspecified)
Indication DetailsTreat Wiskott-Aldrich syndrome
Regulatory Designation EU - Orphan Drug (Treat Wiskott-Aldrich syndrome)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today